[1]
Udosen, I. 2020. Protein Kinase C inhibitor Molecule Effect Partial Reversal of Spliceopathy in Myotonic Dystrophy Type 2 Cell Line: Journal of Natural Sciences Research, Vol.11, No.14. Afrischolar Discovery Repository (Annex). (Aug. 2020), 17–22. DOI:https://doi.org/10.60951/afrischolar-545.